Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $63.8 million.

  • Surgery Partners' Free Cash Flow rose 4177.78% to $63.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.1 million, marking a year-over-year increase of 1878.82%. This contributed to the annual value of $209.7 million for FY2024, which is 229.27% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Free Cash Flow is $63.8 million, which was up 4177.78% from $57.9 million recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Free Cash Flow ranged from a high of $89.1 million in Q4 2024 and a low of -$16.7 million during Q1 2025
  • Moreover, its 5-year median value for Free Cash Flow was $35.7 million (2021), whereas its average is $33.0 million.
  • The largest annual percentage gain for Surgery Partners' Free Cash Flow in the last 5 years was 216666.67% (2022), contrasted with its biggest fall of 37678.57% (2022).
  • Surgery Partners' Free Cash Flow (Quarter) stood at $5.6 million in 2021, then plummeted by 376.79% to -$15.5 million in 2022, then skyrocketed by 376.13% to $42.8 million in 2023, then surged by 108.18% to $89.1 million in 2024, then dropped by 28.4% to $63.8 million in 2025.
  • Its Free Cash Flow was $63.8 million in Q3 2025, compared to $57.9 million in Q2 2025 and -$16.7 million in Q1 2025.